[Trials in Pressure Regulation with Metipranolol Eyedrops in Special Forms of Glaucoma in Ophthalmologic Practice]
Overview
Authors
Affiliations
This paper presents the results of a study on the effect of Metipranolol eye drops (Betamann) in 10 patients. The drops were tested with the following forms of glaucoma: glaucoma associated with alpha-kia, neovascular glaucoma, exfoliative glaucoma, pigmentary glaucoma, juvenile glaucoma. Some patients required treatment in combination with miotics. Metipranolol eye drops reduced intraocular pressure by about 15 percent for a prolonged period of time. The pressure-lowering effect was maintained during an observation period of twelve months. Visual acuity and visual fields were constant. The drug was tolerated well subjectively by almost all the patients.
Battershill P, Sorkin E Drugs. 1988; 36(5):601-15.
PMID: 2905641 DOI: 10.2165/00003495-198836050-00004.
A study on the ocular and extraocular pharmacology of metipranolol.
SUGRUE M, Armstrong J, Gautheron P, Mallorga P, Viader M Graefes Arch Clin Exp Ophthalmol. 1985; 222(3):123-7.
PMID: 2858433 DOI: 10.1007/BF02173535.